ProteomeLab PF2D
Symposium on Protein Fractionation

Posters (in PDF format)

• Using the Biomek 3000 Laboratory Automation Workstation to Interface 2D Liquid Chromatography with Mass Spectrometry for Multidimensional Proteome Profiling
• Proteome Profiling of Extracellular Matrix-induced Modulation of a Human Bladder Cancer Cell Line
• Characterization of Glycoproteins in the Human Plasma Proteome
• Multiplexed Cytokine Immunoassays Using A2 MicroArray System
• Long-Term Expression of Anti-HIV-1 shRNA in CD34+ Cells Does Not Induce the Interferon Response or Change the Cytokine Production Profile
• A "Divide and Conquer" Strategy for Simplifying the Analysis of Proteomes
• Abundant-Protein Depletion Coupled with Multidimensional Fractionation of the Human Plasma Proteome
• ProteomeLab PF 2D Analysis of Gliomas Treated with Novel Platinum Compounds
• ProteomeLab PF 2D Analysis of Genetically-Characterized Human Glioma Xenografts
• Automated Strategies for Fractionating and Characterizing Proteomes

Presentations (in PDF format)

• A Protein Expression analysis of Healthy and Diseased Patient Amniotic Fluid Samples Using ProteomeLab PF 2D: A Case Study on Sample Processing.
  Timothy J. Barder, Ph.D.
• 2D Liquid-Phase Proteomic Profiling in Pre- Clinical and Mechanistic Analysis of Novel Polynuclear Chemotherapeutics for Glioma
  Oliver Bogler, PhD
• Applying a "Divide and Conquer" Strategy to Biomarker Discovery
  J.D. Chapman
• Proteomic Analysis of Organ-Specific Breast Cancer Metastasis
  Emily I. Chen, Ph.D
• Suppression of the Malignant Phenotype of Bladder Cancer Cells Investigations of the Proteome in Relation to Phenotype and Gene Expression
  Robert Hurst, Ph.D.
• Top Down Mass Spectrometry on a Proteomic Scale?
  Neil L. Kelleher
• 2D Liquid Mass Mapping of Cancer Cell Lysates
  David Lubman, Ph.D.
• Integrating Cytomics with Proteomics
  J. Paul Robinson
• Expanding the proteome by combining 2DE and 2DLC: lessons from mitochondria and serum
  Jenny Van Eyk